{"nct_id":"NCT01927419","title":"Study of Nivolumab (BMS-936558) Plus Ipilimumab Compared With Ipilimumab Alone in the Treatment of Previously Untreated, Unresectable, or Metastatic Melanoma","status":"COMPLETED","status_verified_date":"2022-02","start_date":"2013-08-23","start_date_type":"ACTUAL","primary_completion_date":"2014-07-24","primary_completion_date_type":"ACTUAL","completion_date":"2021-02-26","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BMY"]}